HHS Public Health Policy Actions Under the Trump Administration 2025-2026 - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Public Health Policy Initiatives by HHS During the Trump Administration (2025-2026)

  • By

  • Josh Michaud

  • Jennifer Kates

  • June 30, 2026

Share

Clinical Scorecard: Public Health Policy Initiatives by HHS During the Trump Administration (2025-2026)

At a Glance

CategoryDetail
ConditionPublic Health Policy Actions
Key MechanismsPolicy actions instituted by HHS under the Trump Administration
Target PopulationGeneral U.S. population
Care SettingPublic health policy context

Key Highlights

  • Numerous policy actions affecting public health initiated by HHS
  • Actions listed chronologically with descriptions
  • Resource updated to reflect new developments
  • Not exhaustive of all public health-related federal policy changes
  • Additional resources available on specific health topics

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          General U.S. population

          Not applicable as the document focuses on policy actions

          Clinical Best Practices

            Related Resources & Content

              Original Source(s)

              HHS Public Health Policy Actions Under the Trump Administration 2025-2026

              • by Josh Michaud, Jennifer Kates

              • June 30, 2026

              Related Content

              Top 10 CDC Updates Physicians Should Know

              Recent CDC advisories, testing updates, and immunization recommendations highlight developments in infectious diseases, immunization, and diagnostic testing relevant to physicians across multiple specialties.

              3 Things to Know About Substance Use and Suicide Mortality

              Can Controlled Breathing Reduce Substance Craving?

              A systematic review and meta-analysis found small, consistent reductions in craving across substance use disorders, while evidence for withdrawal symptoms and substance dependence remained limited.